Korean J Urol.  2015 Dec;56(12):817-822. 10.4111/kju.2015.56.12.817.

Characteristics of urinary retention in female inpatients managed with medical treatments

• Lee CY
• Kim CS
• Cho WJ

• KMID: 2359874
• DOI: http://doi.org/10.4111/kju.2015.56.12.817

Abstract

PURPOSE
We aimed to analyze the characteristics of urinary retention (UR) in female inpatients managed with medical treatments.
MATERIALS AND METHODS
We retrospectively analyzed the medical records of female inpatients referred to the department of urology for UR at our institution from January 2009, to December 2014. UR was defined as a difficulty in self-voiding despite a sufficient urine volume or >300-mL postvoid residual. The data included patients' age, body mass index (BMI), ambulatory status, medical and surgical history, classes of taking drugs, and urinary tract infection.
RESULTS
A total of 182 women were included as retention group, mean age of 72.64±12.94 years and BMI of 22.94±3.10 kg/m2. In the chi-square analysis, cardiovascular disorders (p=0.000), diabetes mellitus (p=0.008), metastatic malignancy (p=0.008), chronic renal disorders (p=0.028) were found significantly. In the multiple logistic regression analysis, cardiovascular disorders (p=0.002; odds ratio [OR], 0.491), metastatic malignancy (p=0.013; OR, 2.616) were found to increase the risk of UR. The most common surgical history was anti-incontinence surgery (7.2%). In term of medication use, the most prescribed agents were nonsteroidal anti-inflammatory drugs (NSAIDs) (53.8%). The patients taking multiple drugs with antimuscarinic effects except of NSAIDs, narcotics and diuretics were 48 (26.4%). Urinary tract infection was identified in 43 patients (23.6%).
CONCLUSIONS
UR in females managed with medical treatments could be occurred occasionally. We think that thorough attentions are needed for UR to patients with cardiovascular disorders including diabetes mellitus, metastatic malignancy, chronic renal disorders urinary tract infection, and more careful interests when managing with drugs with antimuscarinic effects.

Keyword

Antimuscarinic agents; Drug therapy; Female; Urinary retention

MeSH Terms

Age Factors
Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
Cardiovascular Diseases/complications
Diabetes Complications
Female
Hospitalization
Humans
Kidney Diseases/complications
Middle Aged
Muscarinic Antagonists/adverse effects
Neoplasm Metastasis
Retrospective Studies
Risk Factors
Urinary Retention/diagnosis/*etiology/therapy
Urinary Tract Infections/etiology
Anti-Inflammatory Agents, Non-Steroidal
Muscarinic Antagonists

Reference

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002; 21:167–178.

2. Mevcha A, Drake MJ. Etiology and management of urinary retention in women. Indian J Urol. 2010; 26:230–235.

3. Klarskov P, Andersen JT, Asmussen CF, Brenøe J, Jensen SK, Jensen IL, et al. Acute urinary retention in women: a prospective study of 18 consecutive cases. Scand J Urol Nephrol. 1987; 21:29–31.

4. van der Linden EF, Venema PL. Acute urinary retention in women. Ned Tijdschr Geneeskd. 1998; 142:1603–1606.

5. Ramsey S, Palmer M. The management of female urinary retention. Int Urol Nephrol. 2006; 38:533–535.

6. Garcia-Fadrique G, Morales G, Arlandis S, Bonillo MA, Jimenez-Cruz JF. Causes, characteristics and mid-term course of acute urinary retention in women referred to a urodynamics unit. Actas Urol Esp. 2011; 35:389–393.

7. Madani AH, Aval HB, Mokhtari G, Nasseh H, Esmaeili S, Shakiba M, et al. Effectiveness of tamsulosin in prevention of post-operative urinary retention: a randomized double-blind placebo-controlled study. Int Braz J Urol. 2014; 40:30–36.

8. Lee SJ, Kim YT, Lee TY, Woo YN. Analysis of risk factors for acute urinary retention after non-urogenital surgery. Korean J Urol. 2007; 48:1277–1284.

9. Geller EJ. Prevention and management of postoperative urinary retention after urogynecologic surgery. Int J Womens Health. 2014; 6:829–838.

10. Baldini G, Bagry H, Aprikian A, Carli F. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology. 2009; 110:1139–1157.

11. Lee GJ, Kim MS, Song SM, Rho J, Cho WJ. Roles of urology as assessed by an analysis of inpatients referred to urology. Korean J Urol. 2012; 53:619–624.

12. Gerber GS, Brendler CB. Evaluation of the urologic patient: history, physical examination, and urinalysis. In : Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peter CA, editors. Campbell-Walsh Urology. 10th ed. Philadelphia: Saunders;2011. p. 73–98.

13. Oelke M, Burger M, Castro-Diaz D, Chartier-Kastler E, Jimenez Cidre MA, McNicholas T, et al. Diagnosis and medical treatment of lower urinary tract symptoms in adult men: applying specialist guidelines in clinical practice. BJU Int. 2012; 110:710–718.

14. Gates MA, Hall SA, Chiu GR, Kupelian V, Fitzgerald MP, Link CL, et al. Nonsteroidal antiinflammatory drug use and lower urinary tract symptoms: results from the Boston area community health survey. Am J Epidemiol. 2011; 173:1022–1031.

15. Bratslavsky G, Kogan BA, Matsumoto S, Aslan AR, Levin RM. Reperfusion injury of the rat bladder is worse than ischemia. J Urol. 2003; 170:2086–2090.

16. Elneil S. Urinary retention in women and sacral neuromodulation. Int Urogynecol J. 2010; 21:Suppl 2. S475–S483.

17. Barrett DM. Psychogenic urinary retention in women. Mayo Clin Proc. 1976; 51:351–356.

18. Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014; 65:389–398.

19. Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, et al. Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol. 2012; 53:342–348.

20. Fitzgerald MP, Link CL, Litman HJ, Travison TG, McKinlay JB. Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol. 2007; 52:407–415.

21. Andersson KE, Nomiya M, Sawada N, Yamaguchi O. Pharmacological treatment of chronic pelvic ischemia. Ther Adv Urol. 2014; 6:105–114.

22. Pinggera GM, Mitterberger M, Steiner E, Pallwein L, Frauscher F, Aigner F, et al. Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography. BJU Int. 2008; 102:470–474.

23. Kupelian V, Rosen RC, Link CL, McVary KT, Aiyer LP, Mollon P, et al. Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey. J Urol. 2009; 181:694–700.

24. Frimodt-Moller C. Diabetic cystopathy: a review of the urodynamic and clinical features of neurogenic bladder dysfunction in diabetes mellitus. Dan Med Bull. 1978; 25:49–60.

25. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int. 2005; 95:733–738.

26. Natale F, La Penna C, Saltari M, Piccione E, Cervigni M. Voiding dysfunction after anti-incontinence surgery. Minerva Ginecol. 2009; 61:167–172.

27. Siddighi S, Karram MM. Surgical and nonsurgical approaches to treat voiding dysfunction following antiincontinence surgery. Curr Opin Obstet Gynecol. 2007; 19:490–495.

28. Hall SA, Yang M, Gates MA, Steers WD, Tennstedt SL, McKinlay JB. Associations of commonly used medications with urinary incontinence in a community based sample. J Urol. 2012; 188:183–189.

29. Verhamme KM, Sturkenboom MC, Stricker BH, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Saf. 2008; 31:373–388.